Population-based programs for increasing colorectal cancer screening in the United States

CA Cancer Journal for Clinicians

Volumn 65, Issue 6, 2015, Pages 496-510

  Verma, Manisha ^a   Sarfaty, Mona ^b   Brooks, Durado ^c   Wender, Richard C ^c  

^a Einstein Healthcare Network   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

Author keywords

colorectal cancer screening; mass screening; organized screening program; population management; prevention program

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DISEASE SURVEILLANCE; FUNDING; HEALTH CARE POLICY; HUMAN; LOWEST INCOME GROUP; MASS SCREENING; MEDICALLY UNINSURED; OCCULT BLOOD TEST; PATIENT EDUCATION; PATIENT PARTICIPATION; PRIORITY JOURNAL; SIGMOIDOSCOPY; UNITED STATES; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; PREVENTIVE HEALTH SERVICE; PROCEDURES;

COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 84947019917     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21295     Document Type: Article

References (116)

1. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 627-637.
2. Rex DK, Johnson DA, Anderson JC, et al,; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009; 104: 739-750.
3. Levin B, Lieberman DA, McFarland B, et al,; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008; 58: 130-160.
4. Smith RA, Manassaram-Baptiste D, Brooks D, et al., Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015; 65: 30-54.
5. Zavon MR,. Principles and practice of screening for disease. Arch Intern Med. 1969; 123: 349-349.
6. Heitman SJ, Hilsden RJ, Au F, Dowden S, Manns BJ,. Colorectal cancer screening for average-risk North Americans: an economic evaluation [serial online]. PLoS Med. 2010; 7: e1000370.
7. Edwards BK, Ward E, Kohler BA, et al., Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544-573.
8. Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29.
9. Steinwachs D, Allen JD, Barlow WE, et al., National Institutes of Health state-of-the-science conference statement: enhancing use and quality of colorectal cancer screening. Ann Intern Med. 2010; 152: 663-667.
10. Laiyemo AO,. Reducing racial disparity in colorectal cancer burden. Dig Dis Sci. 2014; 59: 2025-2027.
11. Mishuris RG, Linder JA,. Racial differences in cancer screening with electronic health records and electronic preventive care reminders [serial online]. J Am Med Inform Assoc. 2014; 21: e264-e269.
12. Naylor K, Ward J, Polite BN,. Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review. J Gen Intern Med. 2012; 27: 1033-1046.
13. Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC,; Centers for Disease Control and Prevention (CDC). Colorectal cancer screening-United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ. 2011; 60 (suppl): 42-46.
14. Taunk P, Calderwood AH,. Colorectal cancer: screening and surveillance recommendations. J Clin Outcomes Manage. 2015; 22: 130-142.
15. Miles A, Cockburn J, Smith RA, Wardle J,. A perspective from countries using organized screening programs. Cancer. 2004; 101 (5 suppl): 1201-1213.
16. Guy GP Jr, Richardson LC, Pignone MP, Plescia M,. Costs and benefits of an organized fecal immunochemical test-based colorectal cancer screening program in the United States. Cancer. 2014; 120: 2308-2315.
17. Rabeneck L,. What can we do about low colorectal cancer screening rates? Am J Gastroenterol. 2007; 102: 1736-1738.
18. Sarfaty M,. How to Increase Colorectal Cancer Screening Rates in Practice: A Primary Care Clinician's Evidence Based Toolbox and Guide 2008. American Cancer Society. cancer.org/acs/groups/content/documents/document/acspc-024588.pdf. Accessed April 10, 2015.
19. De la Cruz MS, Sarfaty, M,. Steps for Increasing Colorectal Cancer Screening Rates: A Manual for Community Health Centers. American Cancer Society/National Colorectal Cancer Roundtable. nccrt.org/wp-content/uploads/0305.60-Colorectal-Cancer-Manual-FULFILL.pdf. Accessed April 10, 2015.
20. Baron RC, Rimer BK, Breslow RA, et al., Task Force on Community Preventive Services. Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening: a systematic review. Am J Prev Med. 2008; 35 (1 suppl): S34-S55.
21. Sabatino SA, Habarta N, Baron RC, et al., Task Force on Community Preventive Services. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers: systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med. 2008; 35 (1 suppl): S67-S74.
22. Brawley OW,. Colorectal cancer control: providing adequate care to those who need it [serial online]. J Natl Cancer Inst. 2014; 106: dju075.
23. Potter MB,. Strategies and resources to address colorectal cancer screening rates and disparities in the United States and globally. Annu Rev Public Health. 2013; 34: 413-429.
24. Swan H, Siddiqui AA, Myers RE,. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates. Practical Gastroenterol. 2012; 36: 20-29.
25. Benson VS, Patnick J, Davies AK, et al., International Colorectal Cancer Screening Network. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008; 122: 1357-1367.
26. International Agency for Research on Cancer (IARC), World Health Organization. IARC Working Group on the Evaluation of Cancer-Preventive Strategies, ed. IARC Handbooks of Cancer Prevention. Volume 10. Lyon, France: IARC Press; 2005: 117-162.
27. Joseph DA, King JB, Miller JW, Richardson LC,; Centers for Disease Control and Prevention (CDC). Prevalence of colorectal cancer screening among adults-Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61 (suppl): 51-56.
28. Seeff LC, DeGroff A, Tangka F, et al., Development of a federally funded demonstration colorectal cancer screening program [serial online]. Prev Chronic Dis. 2008; 5: A64.
29. Seeff LC, DeGroff A, Joseph DA, et al., Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts. Cancer. 2013; 119 (15 suppl): 2940-2946.
30. Glover-Kudon R, DeGroff A, Rohan EA, Preissle J, Boehm JE,. Developmental milestones across the programmatic life cycle: implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (15 suppl): 2926-2939.
31. Seeff LC, Royalty J, Helsel WE, et al., Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (15 suppl): 2820-2833.
32. Seeff LC, Rohan EA,. Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (15 suppl): 2817-2819.
33. Rohan EA, Boehm JE, DeGroff A, Glover-Kudon R, Preissle J,. Implementing the CDC's Colorectal Cancer Screening Demonstration Program: wisdom from the field. Cancer. 2013; 119 (15 suppl): 2870-2883.
34. Boehm JE, Rohan EA, Preissle J, DeGroff A, Glover-Kudon R,. Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (15 suppl): 2914-2925.
35. Nadel MR, Royalty J, Shapiro JA, et al., Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (15 suppl): 2834-2841.
36. Lane DS, Messina CR, Cavanagh MF, Anderson JC,. Delivering colonoscopy screening for low-income populations in Suffolk County. Cancer. 2013; 119 (15 suppl): 2842-2848.
37. Castro G, Azrak MF, Seeff LC, Royalty J,. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (15 suppl): 2849-2854.
38. Subramanian S, Tangka FK, Hoover S, et al., Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013; 119 (15 suppl): 2855-2862.
39. Phillips-Angeles E, Song L, Hannon PA, et al., Fostering partnerships and program success. Cancer. 2013; 119 (15 suppl): 2884-2893.
40. Villanueva R, Gugel D, Dwyer DM,. Collaborating across multiple health care institutions in an urban colorectal cancer screening program. Cancer. 2013; 119 (15 suppl): 2905-2913.
41. DeGroff A, Boehm J, Goode Green S, Holden D, Seeff LC,. Facilitators and challenges to start-up of the colorectal cancer screening demonstration program [serial online]. Prev Chronic Dis. 2008; 5: A39.
42. Tangka FK, Seeff L, DeGroff A, et al., Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs [serial online]. Prev Chronic Dis. 2008; 5: A47.
43. DeGroff A, Holden D, Goode Green S, Boehm J, Seeff L, Tangka F,. Start-up of the colorectal cancer screening demonstration program [serial online]. Prev Chronic Dis. 2008; 5: A38.
44. Winawer S, Fletcher R, Rex D, et al,; Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003; 124: 544-560.
45. Lieberman DA, Rex DK, Winawer SJ, et al,; United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143: 844-857.
46. Joseph DA, DeGroff AS, Hayes NS, Wong FL, Plescia M,. The Colorectal Cancer Control Program: partnering to increase population level screening. Gastrointest Endosc. 2011; 73: 429-434.
47. Jorgensen CM, Gelb CA, Merritt TL, Seeff LC,. Observations from the CDC: CDC's Screen for Life: a national colorectal cancer action campaign. J Womens Health Gend Based Med. 2001; 10: 417-422.
48. Centers for Disease Control and Prevention (CDC). Colorectal Cancer Control Program (CRCCP). cdc.gov/cancer/crccp/about.htm. Accessed May 13, 2015.
49. Jones WJ, Silvestri GA,. The Master Settlement Agreement and its impact on tobacco use 10 years later: lessons for physicians about health policy making. Chest J. 2010; 137: 692-700.
50. National Governors Association. State Tobacco Settlement Spending At-a-Glance. nga.org/files/live/sites/NGA/files/pdf/TOBACCOPLANS.pdf. Accessed May 13, 2015.
51. Delaware Health and Social Services, Division of Public Health. Delaware Cancer Consortium: Turning Commitment Into Action. dhss.delaware.gov/dph/dpc/files/dcc-year3-rpt.pdf. Accessed December 13, 2014.
52. Grubbs SS, Polite BN, Carney J Jr, et al., Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013; 31: 1928-1930.
53. Centers for Disease Control and Prevention (CDC). National Program of Cancer Registries (NPCR). cdc.gov/cancer/npcr/. Accessed December 13, 2014.
54. Delaware Health and Social Services, Division of Public Health. Cancer Incidence and Mortality in Delaware, 2006-2010 (2014). dhss.delaware.gov/dhss/dph/dpc/files/imreport-2006-10.pdf. Accessed December 15, 2014.
55. Delaware Health and Social Services, Division of Public Health. The Delaware Cancer Registry. dhss.delaware.gov/dhss/dph/dcr/home.html. Accessed December 15, 2014.
56. Delaware Health and Social Services, Division of Public Health. Behavioral Risk Factor Surveillance. dhss.delaware.gov/dph/dpc/aboutbrfss.html. Accessed October 3, 2014.
57. Maryland Department of Health and Mental Hygiene. Cancer Prevention, Education, Screening, and Treatment Program-Colorectal Cancer Screening. phpa.dhmh.maryland.gov/cancer/SitePages/crc-screening.aspx. Accessed October 3, 2014.
58. Dwyer DM, Groves C, Hopkins A, et al., Experience of a public health colorectal cancer testing program in Maryland. Public Health Rep. 2012; 127: 330-339.
59. Maryland Department of Health and Mental Hygiene. Maryland Colorectal Cancer (CRC) Program Information. phpa.dhmh.maryland.gov/cancer/Shared%20Documents/CRF-CRC-ProgInfo-06-30-2013%20(1).pdf. Accessed June 5, 2015.
60. Center for Cancer Surveillance and Control, Maryland Department of Health and Mental Hygiene. Colorectal Cancer Disparities in Maryland 2002-2010. phpa.dhmh.maryland.gov/cancer/SiteAssets/SitePages/crccp/Final%20Colorectal%20Cancer%20Disparities%20Report%20-%2072dpi.pdf. Accessed June 5, 2015.
61. The New York City Department of Health and Mental Hygiene and the Citywide Colon Cancer Control Coalition. Cancer Information for Providers. nyc.gov/html/doh/html/hcp/cancer-colon-coalition.shtml. Accessed October 7, 2014.
62. Richards CA, Kerker BD, Thorpe L, et al., Increased screening colonoscopy rates and reduced racial disparities in the New York Citywide campaign: an urban model. Am J Gastroenterol. 2011; 106: 1880-1886.
63. Cancer Prevention and Control Program, Bureau of Chronic Disease Prevention and Control, The New York City Department of Health and Mental Hygiene, and New York Citywide Colon Cancer Control Coalition. A practical guide to increasing screening colonoscopy. November 2006. nyc.gov/html/doh/downloads/pdf/cancer/cancer-colonoscopy-guide.pdf. Accessed February 13, 2015.
64. Lewis B, Henick A,. How we leveled the CRC screening playing field. American Gastroenterological Association Perspectives. November 2014. gastro.org/journals-publications/aga-perspectives/octobernovember2014/how-we-leveled-the-crc-screening-playing-field. Accessed April 4, 2015.
65. The New York City Department of Health and Mental Hygiene. The NYC Colonoscopy Navigation Program. nyc.gov/html/doh/downloads/pdf/cancer/colon-patient-toolkit.pdf. Accessed October 7, 2014.
66. Petersen BT,. Quality assurance for endoscopists. Best Pract Res Clin Gastroenterol. 2011; 25: 349-360.
67. The New York City Department of Health and Mental Hygiene. The NYC Colonoscopy Quality Benchmarking Group (NYC CQBG). nyc.gov/html/doh/downloads/pdf/cancer/colonoscopy-brochure.pdf. Accessed October 7, 2014.
68. The New York City Department of Health and Mental Hygiene. NYC Community CARES Project. cdn.c5nyc.org/wp-content/uploads/sites/36/2014/06/12-M.Carlesimo-A.-Carrascal-Awards-PPT.pdf?f90e8b. Accessed February 13, 2015.
69. Colon Cancer Challenge Foundation. Colon Cancer Challenge Foundation website. coloncancerchallenge.org/. Accessed June 12, 2015.
70. The New York City Department of Health and Mental Hygiene. NYC Community Health Survey 2007-2012. nyc.gov/html/doh/html/data/chs-data.shtml. Accessed December 13, 2014.
71. National Committee for Quality Assurance (NCQA). HEDIS and Performance Measurement. ncqa.org/HEDISQualityMeasurement.aspx. Accessed May 13, 2015.
72. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C,. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011; 33: 101-110.
73. Kaiser Permanente. Colorectal Cancer Screening Clinical Practice Guideline. National Clinical Practice Guideline 2010. providers.kaiserpermanente.org/info-assets/cpp-oh/oh-colorectal-cancer-screening-guideline-0311.pdf. Accessed January 2, 2015.
74. Levin TR,. Editorial: taking FIT to the people: out of the office and into the mail. Am J Gastroenterol. 2012; 107: 108-110.
75. Levin TR,. Optimizing colorectal cancer screening by getting FIT right. Gastroenterology. 2011; 141: 1551-1555.
76. Kempe KL, Shetterly SM, France EK, Levin TR,. Automated phone and mail population outreach to promote colorectal cancer screening. Am J Manag Care. 2012; 18: 370-378.
77. Potter MB, Phengrasamy L, Hudes ES, McPhee SJ, Walsh JM,. Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates. Ann Fam Med. 2009; 7: 17-23.
78. Potter MB, Ackerson LM, Gomez V, et al., Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial. Am J Public Health. 2013; 103: 1128-1133.
79. American Cancer Society. FluFOBT Program Implementation Guide for Primary Care Practices. Atlanta, GA: American Cancer Society; 2014. cancer.org/acs/groups/content/@editorial/documents/document/acspc-040286.pdf. Accessed May 23, 2015.
80. Mosen DM, Feldstein AC, Perrin N, et al., More comprehensive discussion of CRC screening associated with higher screening. Am J Manag Care. 2013; 19: 265-271.
81. Braddock CH 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W,. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999; 282: 2313-2320.
82. National Cancer Institute. Surveillance, Epidemiology, and End Results Program (SEER). seer.cancer.gov/registries/. Accessed October 30, 2014.
83. Moiel D, Thompson J,. Early detection of colon cancer-the Kaiser Permanente Northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients? Perm J. 2011; 15: 30-38.
84. Mandelson MT, Thompson RS,. Cancer screening in HMOs: program development and evaluation. Am J Prev Med. 1998; 14: 26-32.
85. Miglioretti DL, Rutter CM, Bradford SC, et al., Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care. 2008; 46 (9 suppl 1): S91-S96.
86. Coleman K, Austin B, Brach C, Wagner EH,. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood). 2009; 28: 75-85.
87. Group Health Cooperative of Puget Sound. Colorectal cancer screening guidelines. ghc.org/all-sites/guidelines/colon.pdf. Accessed October 25, 2014.
88. Green BB, Wang CY, Horner K, et al., Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010; 31: 589-603.
89. Green BB, Wang CY, Anderson ML, et al., An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013; 158 (5 pt 1): 301-311.
90. Hsu C, Coleman K, Ross TR, et al., Spreading a patient-centered medical home redesign: a case study. J Ambul Care Manage. 2012; 35: 99-108.
91. Wang CY, de Dieu Tapsoba J, Anderson ML, et al., Time to screening in the Systems of Support to Increase Colorectal Cancer Screening trial. Cancer Epidemiol Biomarkers Prev. 2014; 23: 1683-1688.
92. Green BB, Anderson ML, Wang CY, et al., Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014; 27: 789-795.
93. Murphy CC, Vernon SW, Haddock NM, Anderson ML, Chubak J, Green BB,. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014; 66: 123-130.
94. Jha AK, Perlin JB, Kizer KW, Dudley RA,. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003; 348: 2218-2227.
95. Chao HH, Schwartz AR, Hersh J, et al., Improving colorectal cancer screening and care in the Veterans Affairs Healthcare system. Clin Colorectal Cancer. 2009; 8: 22-28.
96. Jackson GL, Powell AA, Ordin DL, et al., Developing and sustaining quality improvement partnerships in the VA: the Colorectal Cancer Care Collaborative. J Gen Intern Med. 2010; 25: 38-43.
97. Long MD, Lance T, Robertson D, Kahwati L, Kinsinger L, Fisher DA,. Colorectal cancer testing in the national Veterans Health Administration. Dig Dis Sci. 2012; 57: 288-293.
98. Taylor MJ, McNicholas C, Nicolay C, Darzi A, Bell D, Reed JE,. Systematic review of the application of the plan-do-study-act method to improve quality in healthcare. BMJ Qual Saf. 2014; 23: 290-298.
99. Trivedi AN, Grebla RC,. Quality and equity of care in the Veterans Affairs Health-Care System and in Medicare Advantage health plans. Med Care. 2011; 49: 560-568.
100. Powell AA, Gravely AA, Ordin DL, Schlosser JE, Partin MR,. Timely follow-up of positive fecal occult blood tests: strategies associated with improvement. Am J Prev Med. 2009; 37: 87-93.
101. Powell AA, Nugent S, Ordin DL, Noorbaloochi S, Partin MR,. Evaluation of a VHA collaborative to improve follow-up after a positive colorectal cancer screening test. Med Care. 2011; 49: 897-903.
102. Yano EM, Soban LM, Parkerton PH, Etzioni DA,. Primary care practice organization influences colorectal cancer screening performance. Health Serv Res. 2007; 42 (3 pt 1): 1130-1149.
103. Partin MR, Burgess DJ, Burgess JF, et al., Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study. Cancer Epidemiol Biomarkers Prev. 2015; 24: 422-434.
104. Jackson GL, Zullig LL, Zafar SY, et al., Using NCCN clinical practice guidelines in oncology to measure the quality of colorectal cancer care in the Veterans Health Administration. J Natl Compr Cancer Netw. 2013; 11: 431-441.
105. Battat AC, Rouse RV, Dempsey L, Safadi BY, Wren SM,. Institutional commitment to rectal cancer screening results in earlier-stage cancers on diagnosis. Ann Surg Oncol. 2004; 11: 970-976.
106. Trombold J, Farmer RW, McCafferty M,. The impact of colorectal cancer screening in a veteran hospital population. Am Surg. 2013; 79: 296-300.
107. Snyder RA, Mainthia R, Patel R, Dittus RS, Roumie CL,. Quality of colorectal cancer care among veterans: a 10-year retrospective cohort. Ann Surg Oncol. 2014; 21: 2476-2483.
108. Independence Blue Cross. Navinet provider portal. ibx.com/providers/interactive-tools/navinet/index.html. Accessed April 5, 2015.
109. Gabbay RA, Bailit MH, Mauger DT, Wagner EH, Siminerio L,. Multipayer patient-centered medical home implementation guided by the chronic care model. Jt Comm J Qual Patient Saf. 2011; 37: 265-273.
110. Stange KC, Nutting PA, Miller WL, et al., Defining and measuring the patient-centered medical home. J Gen Intern Med. 2010; 25: 601-612.
111. Higgins S, Chawla R, Colombo C, Snyder R, Nigam S,. Medical homes and cost and utilization among high-risk patients. Am J Manag Care. 2014; 20: e61-e71.
112. Ferrat E, Le Breton J, Veerabudun K, et al., Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer. 2013; 109: 1437-1444.
113. Maryland Department of Health and Mental Hygiene. Ideal Model for Colorectal Cancer Control: Groups Involved and Their Optimal Features. phpa.dhmh.maryland.gov/cancer/cancerplan/pdf/Ideal%20Model-CRC.pdf. Accessed November 13, 2014.
114. Winawer SJ, Zauber AG, Fletcher RH, et al., Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006; 56: 143-159.
115. Rapuri S, Spencer J, Eckels D,. Importance of postpolypectomy surveillance and postpolypectomy compliance to follow-up screening-review of literature. Int J Colorectal Dis. 2008; 23: 453-459.
116. Sarfaty M, Wender R, Smith R,. Promoting cancer screening within the patient centered medical home. CA Cancer J Clin. 2011; 61: 397-408.